336 related articles for article (PubMed ID: 22664175)
1. Mesodermal expression of Fgfr2S252W is necessary and sufficient to induce craniosynostosis in a mouse model of Apert syndrome.
Holmes G; Basilico C
Dev Biol; 2012 Aug; 368(2):283-93. PubMed ID: 22664175
[TBL] [Abstract][Full Text] [Related]
2. Morphological comparison of the craniofacial phenotypes of mouse models expressing the Apert FGFR2 S252W mutation in neural crest- or mesoderm-derived tissues.
Heuzé Y; Singh N; Basilico C; Jabs EW; Holmes G; Richtsmeier JT
Bone; 2014 Jun; 63():101-9. PubMed ID: 24632501
[TBL] [Abstract][Full Text] [Related]
3. EphA4 as an effector of Twist1 in the guidance of osteogenic precursor cells during calvarial bone growth and in craniosynostosis.
Ting MC; Wu NL; Roybal PG; Sun J; Liu L; Yen Y; Maxson RE
Development; 2009 Mar; 136(5):855-64. PubMed ID: 19201948
[TBL] [Abstract][Full Text] [Related]
4. Cell mixing at a neural crest-mesoderm boundary and deficient ephrin-Eph signaling in the pathogenesis of craniosynostosis.
Merrill AE; Bochukova EG; Brugger SM; Ishii M; Pilz DT; Wall SA; Lyons KM; Wilkie AO; Maxson RE
Hum Mol Genet; 2006 Apr; 15(8):1319-28. PubMed ID: 16540516
[TBL] [Abstract][Full Text] [Related]
5. A Pro253Arg mutation in fibroblast growth factor receptor 2 (Fgfr2) causes skeleton malformation mimicking human Apert syndrome by affecting both chondrogenesis and osteogenesis.
Yin L; Du X; Li C; Xu X; Chen Z; Su N; Zhao L; Qi H; Li F; Xue J; Yang J; Jin M; Deng C; Chen L
Bone; 2008 Apr; 42(4):631-43. PubMed ID: 18242159
[TBL] [Abstract][Full Text] [Related]
6. Craniofacial divergence by distinct prenatal growth patterns in Fgfr2 mutant mice.
Motch Perrine SM; Cole TM; Martínez-Abadías N; Aldridge K; Jabs EW; Richtsmeier JT
BMC Dev Biol; 2014 Feb; 14():8. PubMed ID: 24580805
[TBL] [Abstract][Full Text] [Related]
7. Apert syndrome mutant FGFR2 and its soluble form reciprocally alter osteogenesis of primary calvarial osteoblasts.
Suzuki H; Suda N; Shiga M; Kobayashi Y; Nakamura M; Iseki S; Moriyama K
J Cell Physiol; 2012 Sep; 227(9):3267-77. PubMed ID: 22105374
[TBL] [Abstract][Full Text] [Related]
8. Beyond the closed suture in apert syndrome mouse models: evidence of primary effects of FGFR2 signaling on facial shape at birth.
Martínez-Abadías N; Percival C; Aldridge K; Hill CA; Ryan T; Sirivunnabood S; Wang Y; Jabs EW; Richtsmeier JT
Dev Dyn; 2010 Nov; 239(11):3058-71. PubMed ID: 20842696
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic effect of nanogel-based delivery of soluble FGFR2 with S252W mutation on craniosynostosis.
Yokota M; Kobayashi Y; Morita J; Suzuki H; Hashimoto Y; Sasaki Y; Akiyoshi K; Moriyama K
PLoS One; 2014; 9(7):e101693. PubMed ID: 25003957
[TBL] [Abstract][Full Text] [Related]
10. PIN1 Attenuation Improves Midface Hypoplasia in a Mouse Model of Apert Syndrome.
Kim B; Shin H; Kim W; Kim H; Cho Y; Yoon H; Baek J; Woo K; Lee Y; Ryoo H
J Dent Res; 2020 Feb; 99(2):223-232. PubMed ID: 31869252
[TBL] [Abstract][Full Text] [Related]
11. Altered bone growth dynamics prefigure craniosynostosis in a zebrafish model of Saethre-Chotzen syndrome.
Teng CS; Ting MC; Farmer DT; Brockop M; Maxson RE; Crump JG
Elife; 2018 Oct; 7():. PubMed ID: 30375332
[TBL] [Abstract][Full Text] [Related]
12. Dysregulated PDGFRα signaling alters coronal suture morphogenesis and leads to craniosynostosis through endochondral ossification.
He F; Soriano P
Development; 2017 Nov; 144(21):4026-4036. PubMed ID: 28947535
[TBL] [Abstract][Full Text] [Related]
13. The Development of the Calvarial Bones and Sutures and the Pathophysiology of Craniosynostosis.
Ishii M; Sun J; Ting MC; Maxson RE
Curr Top Dev Biol; 2015; 115():131-56. PubMed ID: 26589924
[TBL] [Abstract][Full Text] [Related]
14. Aberrantly activated Wnt/β-catenin pathway co-receptors LRP5 and LRP6 regulate osteoblast differentiation in the developing coronal sutures of an Apert syndrome (Fgfr2
Min Swe NM; Kobayashi Y; Kamimoto H; Moriyama K
Dev Dyn; 2021 Mar; 250(3):465-476. PubMed ID: 32822074
[TBL] [Abstract][Full Text] [Related]
15. Early onset of craniosynostosis in an Apert mouse model reveals critical features of this pathology.
Holmes G; Rothschild G; Roy UB; Deng CX; Mansukhani A; Basilico C
Dev Biol; 2009 Apr; 328(2):273-84. PubMed ID: 19389359
[TBL] [Abstract][Full Text] [Related]
16. Activation of p38 MAPK pathway in the skull abnormalities of Apert syndrome Fgfr2(+P253R) mice.
Wang Y; Sun M; Uhlhorn VL; Zhou X; Peter I; Martinez-Abadias N; Hill CA; Percival CJ; Richtsmeier JT; Huso DL; Jabs EW
BMC Dev Biol; 2010 Feb; 10():22. PubMed ID: 20175913
[TBL] [Abstract][Full Text] [Related]
17. Medical treatment of craniosynostosis: recombinant Noggin inhibits coronal suture closure in the rat craniosynostosis model.
Shen K; Krakora SM; Cunningham M; Singh M; Wang X; Hu FZ; Post JC; Ehrlich GD
Orthod Craniofac Res; 2009 Aug; 12(3):254-62. PubMed ID: 19627528
[TBL] [Abstract][Full Text] [Related]
18. Facial suture synostosis of newborn Fgfr1(P250R/+) and Fgfr2(S252W/+) mouse models of Pfeiffer and Apert syndromes.
Purushothaman R; Cox TC; Maga AM; Cunningham ML
Birth Defects Res A Clin Mol Teratol; 2011 Jul; 91(7):603-9. PubMed ID: 21538817
[TBL] [Abstract][Full Text] [Related]
19. Dura in the pathogenesis of syndromic craniosynostosis: fibroblast growth factor receptor 2 mutations in dural cells promote osteogenic proliferation and differentiation of osteoblasts.
Ang BU; Spivak RM; Nah HD; Kirschner RE
J Craniofac Surg; 2010 Mar; 21(2):462-7. PubMed ID: 20489451
[TBL] [Abstract][Full Text] [Related]
20. Soluble form of FGFR2 with S252W partially prevents craniosynostosis of the apert mouse model.
Morita J; Nakamura M; Kobayashi Y; Deng CX; Funato N; Moriyama K
Dev Dyn; 2014 Apr; 243(4):560-7. PubMed ID: 24259495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
